CAdd image
Chonluten
ImmuneSingleAlso known as: Tridecactide
A Khavinson tripeptide bioregulator marketed for respiratory and pulmonary tissue support.
Half-life
—
Common dose
10 – 20 mg
Dosing frequency
Daily
Administration
Subcutaneous
How it works
Theorized to influence bronchial-epithelial gene expression. Limited Western mechanistic data.
Protocol notes
Typical protocols: 10–20 mg subcutaneously daily for 10–20 days, cycled 2–3 times per year.
Reported side effects
Reported as well-tolerated.